Created at Source Raw Value Validated value
Nov. 26, 2021, 10:30 p.m. oms

1. Incidences of all-cause hospital mortality [Time Frame: From the date of Drug administered until the date of hospital discharge or date of death from any cause; whichever came first; assessed up to 28 days] <br/ >2.Evaluation of Clinical progression/deterioration based on an 8-point ordinal scale (recommended by the World Health Organization: Coronavirus disease (COVID-2019) R&D) [time frame up to 7 days] on Day 1; Screening and End of treatment (Day 7) <br/ >Timepoint: 1.Day 1 to Day 28 <br/ >2.Day 1 to Day 7 <br/ >3.From baseline to hospital <br/ >discharge

1. Incidences of all-cause hospital mortality [Time Frame: From the date of Drug administered until the date of hospital discharge or date of death from any cause; whichever came first; assessed up to 28 days] <br/ >2.Evaluation of Clinical progression/deterioration based on an 8-point ordinal scale (recommended by the World Health Organization: Coronavirus disease (COVID-2019) R&D) [time frame up to 7 days] on Day 1; Screening and End of treatment (Day 7) <br/ >Timepoint: 1.Day 1 to Day 28 <br/ >2.Day 1 to Day 7 <br/ >3.From baseline to hospital <br/ >discharge

Nov. 13, 2021, 5:33 p.m. oms

N/A

N/A

Nov. 6, 2020, 11:45 p.m. oms

1. Incidences of all-cause hospital mortality [Time Frame: From the date of Drug administered until the date of hospital discharge or date of death from any cause; whichever came first; assessed up to 28 days] <br/ >2.Evaluation of Clinical progression/deterioration based on an 8-point ordinal scale (recommended by the World Health Organization: Coronavirus disease (COVID-2019) R&D) [time frame up to 7 days] on Day 1; Screening and End of treatment (Day 7) <br/ >Timepoint: 1.Day 1 to Day 28 <br/ >2.Day 1 to Day 7 <br/ >3.From baseline to hospital <br/ >discharge

1. Incidences of all-cause hospital mortality [Time Frame: From the date of Drug administered until the date of hospital discharge or date of death from any cause; whichever came first; assessed up to 28 days] <br/ >2.Evaluation of Clinical progression/deterioration based on an 8-point ordinal scale (recommended by the World Health Organization: Coronavirus disease (COVID-2019) R&D) [time frame up to 7 days] on Day 1; Screening and End of treatment (Day 7) <br/ >Timepoint: 1.Day 1 to Day 28 <br/ >2.Day 1 to Day 7 <br/ >3.From baseline to hospital <br/ >discharge